Combined Raloxifene and Letrozole for Breast Cancer Patients
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference20 articles.
1. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group;Mouridsen;J Clin Oncol,2003
2. Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women;Provinciali;Expert Rev Clin Pharmacol,2016
3. Raloxifene: a selective estrogen receptor modulator (SERM) with multiple target system effects;Muchmore;Oncologist,2000
4. Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice;Kalam;Mol Cell Endocrinol,2016
5. Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor- cycloheximide, for possible therapeutic applications;Verma;Curr Pharm Biotechnol,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach;International Journal of Biological Macromolecules;2023-07
2. Letrozole: Pharmacology, toxicity and potential therapeutic effects;Life Sciences;2022-12
3. Tailoring a new hyperbranched PEGylated dendrimer nano-polymer as a super-adsorbent for magnetic solid-phase extraction and determination of letrozole in biological and pharmaceutical samples;Journal of Molecular Liquids;2021-09
4. Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells;Journal of Taibah University Medical Sciences;2021-02
5. Folic acid-functionalized niosomal nanoparticles for selective dual-drug delivery into breast cancer cells: An in-vitro investigation;Advanced Powder Technology;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3